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The medial habenula (MHb) exhibits exceptionally high levels of nicotinic acetylcholine receptors
(nAChRs), but it remains unclear whether all expressed nAChR subunit mRNAs are translated to form
functional receptors. In particular a4 subunits have not been reported to have any functional role, despite
strong a4 mRNA expression in the ventrolateral MHb. We studied a strain of knock-in mice expressing
fluorescent a4* nAChRs (a4YFP), as well as a knock-in strain expressing hypersensitive a4* nAChRs
(a4L90A). In a4YFP mice, there was strong fluorescence in the ventrolateral MHb. In hypersensitive
a4L90A mice, injections of a low dose of nicotine (0.1 mg/kg) led to strong c-fos expression in only the
ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice. In MHb slice recordings,
ventrolateral neurons from a4L90A mice, but not from WT mice, responded robustly to nicotine (1 mM).
Neurons in the medial aspect of the MHb had >10-fold smaller responses. Thus a4* nAChRs contribute to
the selective activation of a subset of MHb neurons. Subunit composition analysis based on gain-of-
function knock-in mice provides a useful experimental paradigm.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
Nicotinic acetylcholine receptors (nAChRs) are promising drug
targets in the treatment of several CNS disorders such as Alzheim-
er’s disease, schizophrenia, neuropathic pain and substance abuse
(Arneric et al., 2007). Successful treatmentswill require discovery of
agents that select among multiple subtypes of nAChRs (Role, 1992;
Gotti et al., 2007). To choose appropriate drugs and to avoid off-
target effects, one must understand how each nAChR is distributed
among cell types and contributes to neuronal function and behavior.
Despite much progress (e.g., Luetje, 2004), these tasks remain
challenging because we lack tools to unambiguously identify
the subunit make-up of particular nAChRs. Novel subunit-specific
toxins (Janes, 2005) and gene-specific knockout models (Cordero-
Erausquin et al., 2000; Picciotto et al., 2001) have confirmed roles for
certain subunits; however, the expression of multiple subunits
within individual cells renders subunit compensation a possibility
in knockout studies (e.g., Brussaard et al., 1994).: þ1 205 934 6571.
.
Wilmington, DE 19850, USA.
All rights reserved.Definitive identification of nAChR subtypes is especially prob-
lematic for neurons in themedial habenula (MHb), which expresses
the highest levels of nAChRs in the brain (Marks et al., 1998). MHb
expresses mRNAs encoding several different subunits (a3–a7 and
b2–b4) (Sheffield et al., 2000). Pharmacological data suggest that
heteromeric nAChRs, composed of a minimum of a3 and b4
subunits (a3b4*), are a major functional subtype in this nucleus
(Mulle and Changeux, 1990; Quick et al., 1999; Perry et al., 2002;
Whiteaker et al., 2002). While the function(s) of this small
epithalamic nucleus is not well understood (Lecourtier and Kelly,
2007), a3b4*-nAChRs are important for sensitization and self-
administration of opioids in rats (Glick et al., 2006; Taraschenko
et al., 2007). It is not yet known how other nAChR subunits
contribute to the heterogeneous MHb nAChR receptor population
(Connolly et al., 1995). This paper examines the expression of
functional a4 subunits, whose mRNA is also found within the MHb
(Wada et al., 1989; Pauly et al., 1996). a4* nAChRs are thought to be
necessary and sufficient for the expression of behaviors underlying
nicotine addiction including reward, tolerance and sensitization
(Tapper et al., 2004; Maskos et al., 2005), but not withdrawal (Salas
et al., 2004). Also, a4b2* receptors are associated with monogenic
epilepsies (Phillips et al., 1995; Fonck et al., 2003, 2005).
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strategies that use two lines of knock-in mice. One line expresses
fluorescently tagged a4* nAChRs (a4YFP, Nashmi et al., 2007); the
other expresses hypersensitive a4* nAChRs bearing a leucine to
alanine substitution at the M2 90 position (a4L90A, Tapper et al.,
2004; Fonck et al., 2005). The results show the distribution and
function of MHb a4* nAChRs.
2. Materials and methods
Experiments involving mice were performed following the guidelines estab-
lished by each institution’s Animal Care Committee. Mutant mouse lines were
genotyped by PCR analysis of tail DNA.
2.1. In situ hybridization of the a4 subunit mRNA in MHb of C57BL/6J mice
A mouse DNA template encoding the third intracellular loop of the a4 nAChR
subunit was prepared by RT-PCR amplification of mRNA from a mouse septal
neuroblastoma cell line (SN56). The mouse DNA templates were subcloned into
pBluescript SK(þ) and sequenced. The genomic DNA region for a4 had a total of 743
bp (bases 1046–1789). cRNA riboprobes labeled with [35S]UTP (Dupont NEN, Boston,
MA) were synthesized from the mouse DNA templates. Post-fixed 20 mm sections
from C57BL/6J mouse brains were processed for in situ hybridization. Slide-mounted
sections were pre-incubated with 1 mg/ml proteinase K for 10 min at 22 C, then
incubated for 18 h at 60 Cwith a hybridization solution containing [35S]UTP-labeled
cRNA riboprobe (1  107 cpm/ml) in the antisense or sense orientation. The sense
riboprobe gave no signal above background (not shown). Sections were Nissl stained
(0.1% cresyl violet solution, Sigma–Aldrich, Saint-Louis, MO) to help visualize the
MHb.
2.2. Generation and analysis of a4YFP mice
Generation and phenotypic characterization of a4YFP knock-in mice have been
described (Nashmi et al., 2007). Previous studies in vitro (Nashmi et al., 2003) and in
the knock-in mice (Nashmi et al., 2007) showed that YFP inserted in the M3–M4
cytoplasmic loop did not alter the function or distribution of a4* receptors compared
to WT. For fluorescence analysis, mice were sacrificed and fixed by intracardial
perfusion with 4% paraformaldehyde in phosphate-buffered saline (PBS). Brain
coronal sections, 30 mm thick, were sliced with a cryostat and mounted onto glass
slides. Sections of the middle portion of the MHb along its rostro-caudual axis were
selected for these studies. Fluorescence images were collected from a microscope
equipped with a spectrally resolved detector array (LSM 510 Meta; Zeiss, Germany).
Images (12-bit intensity resolution over 1024  1024 pixels) were collected at
wavelengths between 495 and 602 nm with bandwidths of 10.7 nm during excita-
tion of YFP with the 488 nm line of an argon laser (1–10%; 23–114 mW). Specific YFP
fluorescence was isolated from background autofluorescence at each pixel with
a linear unmixing algorithm based on two reference spectra: fluorescence of YFP and
autofluorescence of WT brain sections.
2.3. C-fos immunoreactivity in nicotine-injected mice
Generation and phenotypic characterization of a4L90A mice have been previ-
ously described (Tapper et al., 2004; Fonck et al., 2005; Shao et al., 2008). WT and
homozygous a4L90A mice were subcutaneously injected with 0.1 (n ¼ 5/genotype),
2 (n ¼ 3/genotype) or 10 (n ¼ 3 WT) mg/kg nicotine 1.5 h prior to being eutha-
nized with 2-bromo-2-chloro-1,1,1-trifluoroethane. As a negative control, three WT
and three a4L90A mice were injected with saline 1.5 h prior to euthanasia. Mice
were perfused through the left ventricle with 0.1% heparin in PBS (10 ml) followed
by 4% paraformaldehyde (20 ml). Brains were equilibrated in 25% sucrose before
30 mm thick coronal sections were cut with a cryostat. Brain sections from a4L90A
and WT mice were simultaneously processed. Free-floating sections were reacted
against c-fos polyclonal antibody diluted 1:500 (Santa Cruz biotechnology, CA).
The antigen–antibody signal was detected with a secondary antibody, amplified
with an avidin–biotin reaction (Vector laboratories, Burlingame, CA) and visualized
with diaminobenzidine (Sigma–Aldrich, Saint-Louis, MO).
Initial observations indicated that the distribution pattern of c-fos positive cells
was similar among sections from the rostral, middle and caudal regions of the MHb.
Thus final quantification and statistical analysis were performed on matching (WT
versus a4L90A) sections from the middle portion of the MHb, as for the fluorescence
measurements on a4YFP mice. We compared two cell-counting methodologies: (i)
unbiased stereology using Stereo Investigator software (mbf-bioscience, Williston,
VT) and (ii) direct cell counting. The average number of c-fos positive cells counted
within MHb sections was similar for the two methods. However, the standard
deviation rendered by the unbiased stereology method was larger compared to
direct counts. Unbiased stereology contributed more variability to our measure-
ments because therewas an uneven distribution of c-fos positive cells in theMHb. In
other words, there were cell counts from quadrants in regions with many c-fos
positive cells as well as counts from quadrants with very few or no positive cells.Consequently, we performed our analysis based on direct cell counts. Because the
variance in the data was not randomly distributed in the saline-treated groups,
a non-parametric test, Kruskal–Wallis, followed by Tukey’s test for comparisons,
was used to compare treatment groups (SigmaStat by Systat, San Jose, CA).
2.4. Patch-clamp recording in brain slices
WTand homozygous a4L90A mice were anesthetized with CO2 and decapitated.
Brains were removed and a block of tissue containing the habenula was placed in
ice-cold artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl, 126; NaHCO3,
26; KCl, 2.5; NaH2PO4, 1.25; MgCl2, 1; CaCl2, 2; D-glucose, 25; kynurenic acid, 1;
bubbled with 95% CO2/5% O2. The tissue was glued to the slicing platform of a DSK-
1000 vibratome tissue slicer (Dosaka EM, Kyoto, Japan), and immersed in ACSF. Four
to six coronal slices containing the MHb were maintained for 1–8 h in the pre-
chamber, then individually transferred to a recording chamber mounted to the fixed
stage of an Olympusmicroscope equippedwith DIC optics and an infra-red-sensitive
camera and continuously perfused with ACSF at 1–2 ml min1.
MHb cell recordings were obtained from either the ventromedial area close to
the 3rd ventricle or the ventrolateral area adjacent to the lateral habenula (see
fluorescence in Fig. 1). Patch pipettes contained (in mM): K- or Cs-gluconate, 144;
HEPES, 10; EGTA, 0.2; MgCl2, 3; pH 7.2. Series resistance (uncompensated) and
whole-cell capacitance were monitored throughout the recording. Voltage-clamp
currents were recorded using an AxoPatch (Molecular Devices Axon Instruments)
amplifier, filtered at 1 kHz, digitized at 2 kHz and stored to disk using pCLAMP
(Axon) for off-line analysis. Neurons were included in the analysis if there was
<100 pA leak at –50 mV. Nicotine (diluted in ACSF) was applied by pressure ejection
(1–3 psi, 10 s) using a micropipette positioned <20 mm from the cell. In some
experiments, blockers were added to the ACSF to suppress other responses:
tetrodotoxin (200 nM); D-AP5 (10–20 mM); CNQX (10 mM).
3. Results
3.1. Distribution of a4 mRNA and expression of a4YFP receptors
The distribution of a4 mRNA and a4 protein was assessed by in
situ hybridization in C57BL/6J mice and by fluorescence of tissue
from a4YFP mice, respectively. The signal from hybridized a4
mRNA was concentrated in the ventrolateral region of the MHb,
whereas no signal was detected in the dorsal–medial aspect of the
structure (Fig. 1A and B). A similar distribution pattern of a4 mRNA
within the MHb of C57BL/6J mice appears in the data of Wada et al.
(1989) and of the Allen Brain Atlas (www.brain-map.org).
The brains of a4YFP mice displayed YFP signal in several areas
(Nashmi et al., 2007). The highest intensity was found in the MHb.
YFP fluorescence was localized to the ventrolateral portion of the
MHb, with a distribution pattern strongly resembling that of the in
situ hybridization study (Fig. 1C and E). a4* nAChRs were also
visualized in projection fibers of the fasciculus retroflexus (fr;
Fig.1C and D); other images show that the YFP fluorescence persists
as these fibers reach the interpeduncular nucleus. As negative
control, tissue from WT littermates of a4YFP mice showed no YFP
fluorescence (data not shown).
The a4YFP mice were developed, and have been previously
exploited, to provide quantitative data about protein levels. Thus,
when a4YFP expression in various brain areas (Nashmi et al., 2007)
is compared with the known expression of L-[3H] nicotine binding
in those same brain regions (Marks et al., 1992), a4YFP expression
correlates significantly with nicotine binding (r¼ 0.80; p¼ 0.0005;
Fig. 2A), as expected if a4 subunits are a major component of high-
affinity nicotine binding sites (Marks et al., 1992). Furthermore, in
detailed previous studies of midbrain GABAergic neurons, chronic
nicotine produced 30–50% increases in a4YFP fluorescence, and
this corresponded well with electrophysiologically measured
increases in nAChR responses (Nashmi et al., 2007). Indeed, Nashmi
et al. (2007) pointed out that there is a correlation coefficient,
across nine brain areas, of 0.91 between the percentage upregula-
tion of fluorescence and the percentage upregulation of nicotine
binding (Marks et al., 1992; Nashmi et al., 2007). As observed
here for a4 nAChR subunits, there is often a non-linear or non-
monotonic relation between mRNA expression and protein
expression (Fig. 2B). Overall, the high levels of both a4 mRNA and
Fig. 1. In situ hybridization of a4 subunit mRNA and a4YFP fluorescence in MHb. A cRNA riboprobe labeled with [35S]UTP was synthesized from the mouse DNA template. (A)
Approximately a third of the MHb, the ventrolateral aspect, is strongly labeled by the a4 probe. (B) Same section as in (A) stained with Nissl. (C) Confocal image of an a4YFP mouse
brain section with positive YFP fluorescence in the ventrolateral portion of MHb. a4YFP is also visible in axons of the fasciculus retroflexus fiber tract (fr). (D) Positive YFP fluo-
rescence on a cross-section of the fasciculus retroflexus fiber track (oval shaped). (E) High-power image showing a4YFP in individual MHb neurons. (F) Spectrum (wavelength
versus YFP intensity) of the fluorescence from the MHb of an a4YFP mouse brain section indicating specific YFP signal.
Fig. 2. Relationship between a4YFP fluorescence and nAChR mRNA and protein levels. Plots of nicotine binding versus a4YFP fluorescence (A) and a4 nAChR mRNA versus a4YFP
fluorescence (B) for various brain regions including a linear regression fit (solid line) and the 95% confidence intervals (lighter lines). Nicotine binding and a4 mRNA expression over
various brain regions were taken from Marks et al. (1992). a4YFP fluorescence expression measurements were taken from Nashmi et al. (2007). Point representing the MHb is
shown by the open symbol. Nicotine binding shows a significant positive correlation (r ¼ 0.80; p ¼ 0.0005) with a4YFP fluorescence. a4 mRNA did not correlate significantly
(r ¼ 0.55; p ¼ 0.08) with a4YFP fluorescence.
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tion closely parallels the expression of a4 subunit mRNA, and also
suggest that the a4 subunit may be functionally incorporated into
nAChRs within distinct regions of the MHb.
If a4 subunits normally contribute to receptors in the ventro-
lateral MHb then one expects cells in this region to produce espe-
cially sensitive nicotine responses inmice carrying the a4L90A allele
(Tapper et al., 2004). This hypothesis was tested by assaying low
dose nicotine-induced c-fos expression in vivo and low concentra-
tion nicotine-evoked currents in slices.
3.2. C-fos activation in the MHb of a4L90A mice
We assessed c-fos expression in brain sections of WT and
a4L90A mice by immunohistochemical detection. Consistent with
its role as a transcription factor, c-fos expression was revealed by
the accumulation of chromophore inside cell nuclei. At a dose of
0.1 mg/kg nicotine, the most conspicuous c-fos signal in the brains
of a4L90A mice was found in the MHb. Within the MHb, the
ventrolateral portion displayed a high density of c-fos positive
cells (119  23 cells/MHb-section), while the more dorsomedial
aspects were almost devoid of labeled cells (Fig. 3). The MHb of
WT mice injected with 0.1 mg/kg nicotine showed very few c-fos
positive cells (4.4  2.8 cells/MHb-section). Similar to WT injected
with 0.1 mg/kg nicotine, low numbers of c-fos positive cells were
found in the MHb of both WT and a4L90A mice injected withFig. 3. C-fos immunoreactivity in WT and a4L90A mice. (A) Bright-field image of a coronal s
cells in the MHb. (B) The same section as (A) but at higher magnification. (C) C-fos immun
positive neurons are concentrated in the ventrolateral aspect of the MHb. (D) The same sec
within the MHb (per brain section) of mice treated with either 0.1 mg/kg nicotine or saline. T
and a4L90A following a 0.1 mg/kg nicotine injection (Tukey’s test, *p < 0.0001). Error barssaline solution (WT: 7.0  1.4, a4L90A: 4.3  1.1 cells/MHb-
section). A dose of 0.1 mg/kg nicotine elicited no observable
behavioral effects in WT, while some (2 out of 5) a4L90A mice
injected with the same dose displayed Straub tail (curving of the
tail over the back).
In a4L90A mice, nicotine injections at doses larger than 0.1 mg/
kg revealed heavier and more widespread c-fos labeling in the
MHb (Fig. 4) as well as in other brain regions. Thus, at 10 mg/kg,
all regions of the MHb from WT mice showed c-fos labeling
(Fig. 4C). At the intermediate dose of 2 mg/kg, dorsomedial cells of
the MHb were still much more heavily labeled in MHb of L90A than
of WT mice (Fig. 4A and B). These data imply that, in WT mice,
despite possible differences in subunit composition, nAChRs in all
parts of the ventral MHb are equally sensitive to threshold
concentrations of nicotine (see also electrophysiological evidence
in Fig. 5; Quick et al., 1999). However, interpretation of data at
these higher doses of nicotine is likely complicated by previously
reported motor responses such as stereotypy and tremors (Fonck
et al., 2005). Correlations between c-fos expression in the brains of
a4L90A mice and the resulting behavioral responses (for example,
seizures at 1 mg/kg nicotine) will be the subject of a separate
study. Young (P14–P20, similar to animals used for electrophysi-
ology) a4L90A (n ¼ 3) and WT mice (n ¼ 2) were analyzed for c-fos
expression in the MHb following a 0.1 mg/kg nicotine injection,
revealing a similar expression pattern to that of adult mice (data
not shown).ection of a WT mouse injected with 0.1 mg/kg nicotine showing very few c-fos labeled
oreactivity in MHb of an a4L90A mouse injected with 0.1 mg/kg nicotine. Several c-fos
tion as (C), but at higher magnification. (E) The average number of c-fos positive cells
here is a significant difference in the average number of c-fos labeled cells between WT
indicate the S.E.M.
Fig. 4. C-fos immunoreactivity in WT and a4L90A mice following treatment with high concentrations of nicotine. Bright-field images of coronal sections of WT (A) or a4L90A (B)
mice injected with 2 mg/kg nicotine showing differences in the number of c-fos labeled cells especially in the ventrolateral aspect of the MHb. Bright-field images of coronal
sections of WT (C) mice injected with 10 mg/kg nicotine showing extensive c-fos labeling throughout the ventral portion of the MHb. All animals experienced seizures at the
10 mg/kg dose of nicotine, (a4L90A but not WT mice died following seizures and their brains were not processed further for c-fos). The a4L90A but not WT mice exhibited seizures at
2 mg/kg (see Fonck et al., 2005).
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In neurons from the MHb of WT mice, a low concentration of
nicotine (1 mM) evoked small inward or no currents at holding
potentials of 50 to 90 mV, irrespective of the location of the cell.
Fig. 5A and B shows exemplar traces; and Fig. 5C shows all data.
These findings indicate that all neurons in the WT ventral MHb
have roughly equal sensitivity to a low concentration (1 mM) of
agonist (see Quick et al., 1999), but provide no information on
differential subunit composition of nAChRs. If, however, a4 subunits
participate in a functional receptor population, we would expect
larger responses in a4L90A mice. This result was indeed realized. In
slices obtained from the a4L90A animals, all ventrolateral MHb cells50 pA
10 s
WT L9'
ventrolateral MHbA
ventromedial MHb
WT L9
B
nicotine 1 µM nicotine 1 µM
nicotine 1 µMnicotine 1 µM
Fig. 5. Comparison of nAChR function in MHb neurons from WT and a4L90A mice. Example
fromWT (left traces) and a4L90A (right traces) mice. Holding potential was 50 mV. (C) Scat
current for an individual cell. Filled circles show the group mean. Error bars indicate the Sshowed greatly enhanced responses to 1 mM nicotine (Fig. 5A, right
trace; Fig. 5C); but ventromedial MHb cells (Fig. 5B, right trace)
displayed currents not significantly different in amplitude from
ventromedial MHb cells in WT mice (Fig. 5C). These data are
consistent with the inclusion of a4 subunits into functional nAChRs
on cells in the ventrolateral but not the ventromedial parts of the
MHb.
4. Discussion
These studies illustrate how genetic approaches using knock-in
mice that express fluorescent or hypersensitive nicotinic receptors
can help identify the functional contribution of individual subunitA
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results indicate that functional nAChRs containing a4 subunits are
selectively localized to cells in the ventrolateral region of the MHb.
This conclusion is based on a consistent set of four observations:
the patterns of a4 mRNA labeling in WT MHb; the patterns of
highly sensitive nicotine-induced c-fos reactivity in MHb neurons
from mice expressing hypersensitive a4L90A subunit genes; the
patterns of highly sensitive nicotine-elicited currents in MHb
neurons from mice expressing hypersensitive a4L90A subunit
genes; and the distribution of YFP-tagged a4* nAChRs in a4YFP
mice. Previous data on the two knock-in lines provide ample
assurance that neither the hypersensitive L90A mutation nor the
introduced YFP moiety alter the expression patterns of a4* nAChRs
or the incorporation of a4 subunits into nAChRs (Tapper et al., 2004,
2007; Fonck et al., 2005; Nashmi et al., 2007; Shao et al., 2008).
Subunit composition analysis based on gain-of-function knock-in
may be extended to other nAChR subunit genes or other ligand-
gated ion channels.
These gain-of-function analyses complement pharmacological
studies, especially because there are few agonists, antagonists, or
allosteric modulators selective for single nAChR subtypes. The MHb
is among a group of brain regions that may not express the other-
wise dominant a4b2* nAChR subtype(s) (Marks et al., 1998; Perry
et al., 2002). Previous studies concluded that a plurality of receptors
in this nucleus contains an a3b4 ligand-binding interface, based on
the strong potency of cytisine (Mulle and Changeux, 1990), and the
high sensitivity to the a-conotoxin AuIB (Quick et al., 1999). The
present data suggest the presence of an additional component: an
a4* population of nAChRs within the ventrolateral MHb. The c-fos
stereology data, combined with the knowledge that the MHb is
w1.8 mm in length, allow us to estimate that this population is
w7200 neurons per mouse MHb. Which non-a subunit(s) partner
with MHb a4 to form functional receptors? The a4b2 subunit
combination, widely distributed in the rest of the brain, appears
unlikely because b2 knockout mice retain nicotinic responses in
MHb (Picciotto et al., 1995). Given the preponderance of b4 in the
MHb, we speculate that a4b4* receptors predominate in the
ventrolateral MHb, while the a3b4* subtype(s) is more prevalent in
the medial MHb.
The a4L90A mice are an exon replacement knock-in strain and
do not overexpress receptors. As shown by Tapper et al. (2004) and
by Fonck et al. (2005), a4L90A are present at normal to modestly
less than normal levels; non-cytisine-sensitive high-affinity
receptors are also present at normal levels. The a4L90A mice
develop normally in all respects. While they are hypersensitive to
exogenously administered nicotine, ACh itself is eliminated within
w1 ms by endogenous acetylcholinesterase. Consistent with these
points, previous data show that the a4L90A mice have only subtly
changed baseline physiology, such as a dihydro-b-erythroidine-
sensitive breathing frequency (Shao et al., 2008). It is therefore
unlikely that functional compensation occurs in the medial habe-
nula of the a4L90A strain by alterations in the expression of other
receptors or subunits.
Interestingly, the major projections of the ventral part of the
MHb to the interpeduncular nucleus (IPN) can be divided roughly in
keepingwith our suggesteddistribution ofa4* andnon-a4* receptor
subtypes. There is a striking retrograde labeling of the ventrolateral
MHb that parallels the fluorescent staining (fr; Fig. 1C) after the
caudal/lateral parts of the IPN are injected with dye (Contestabile
and Flumerfelt, 1981). This appears to be the dominant MHb
projection to the IPN, whereas the more medial cell populations
seem to project to the central parts of the IPN (Contestabile and
Flumerfelt, 1981). Thus activation of the different nAChRs in regions
of the MHb may be associated with differential activation of
the subnuclear regions of the IPN, with a corresponding heteroge-
neity of physiological and behavioral effects (Morley, 1986).Overall, the functional relevance of the MHb is not well under-
stood, although given the cholinergic phenotype of cells in ventral
portions of this nucleus, it is likely to be involved in behavioral
processes, such as reward, sleep-wake cycles and learning and
memory, that involve the relay of cholinergic information from the
forebrain to the midbrain (Woolf and Butcher, 1985; Lecourtier and
Kelly, 2007). Perhaps the differential expression of nAChR subtypes
within medial and lateral regions of the MHb, coupled with distinct
efferent targets, allows the MHb-IPN system to organize these
different behaviors. For example, it is tempting to speculate that the
presence of two distinct b4-containing receptors in the medial and
lateral MHb may segregate distinct aspects of addiction, e.g.,
sensitization, drug-seeking and modulation of withdrawal symp-
toms (Salas et al., 2003, 2004; Glick et al., 2006; Taraschenko et al.,
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